BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32833410)

  • 1. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
    Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
    Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pulse steroid treatment of ten days' long on the improvement of bacillary layer detachment in a patient with Vogt-Koyanagi Harada disease.
    Atas F; Kaya M; Saatci AO
    Rom J Ophthalmol; 2021; 65(2):183-186. PubMed ID: 34179585
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacillary Layer Detachment in Acute Vogt-Koyanagi-Harada Disease.
    Ataş F; Kaya M; Saatci AO
    Turk J Ophthalmol; 2022 Dec; 52(6):400-404. PubMed ID: 36578215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
    Li AS; Tang PH; Do DV
    JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
    Ishihara K; Hangai M; Kita M; Yoshimura N
    Ophthalmology; 2009 Sep; 116(9):1799-807. PubMed ID: 19643489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SS OCT and OCT-A Findings in Convalescent Inactive Vogt-Koyanagi-Harada Disease.
    Ben Aoun S; Ksiaa I; Nefzi D; Khochtali S; Jelliti B; Abroug N; Khairallah M
    Ocul Immunol Inflamm; 2024 May; 32(4):407-414. PubMed ID: 37948509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLINICAL FEATURES AND PROGNOSTIC VALUE OF BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE.
    Kwak JJ; Lee J; Byeon SH
    Retina; 2023 Oct; 43(10):1700-1707. PubMed ID: 37315551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Maruyama Y; Kishi S
    Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
    Yamaguchi Y; Otani T; Kishi S
    Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
    Parc C; Guenoun JM; Dhote R; Brézin A
    Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The fundus manifestations and SD-OCT findings of patients with acute Vogt-Koyanagi-Harada disease].
    Li B; Ye JJ; Zhang MF; Li DH
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):436-439. PubMed ID: 28606265
    [No Abstract]   [Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
    Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N
    Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
    Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
    Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].
    Tian S; Yao J; Wang J; Zhang J; Zhou A
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):135-140. PubMed ID: 33509766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.
    Yang HK; Yu HG
    Korean J Ophthalmol; 2009 Dec; 23(4):325-8. PubMed ID: 20046700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
    Lu S; Taban M
    Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease in 3-year-old boy.
    Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
    Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.